“In silico targeting of CYP19A1 and PTPN1 by Nigellidine: A network-based exploration of its antidiabetic pathway interactions” (2026) Indian Journal of Biochemistry and Biophysics (IJBB), 63(5), pp. 506–519. doi:10.56042/ijbb.v63i5.22700.